Good morning :)
Switch to
Place Order

Abbott India Ltd

ABBOTINDIA
Health CarePharmaceuticals
MidcapWith a market cap of ₹42,752 cr, stock is ranked 124
Low RiskStock is 1.46x as volatile as Nifty
20,182.901.81% (-372.75)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹42,752 cr, stock is ranked 124
Low RiskStock is 1.46x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
53.5315.161.37%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.904.360.88%

Forecast & RatingsDetailed Forecast 

56%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Abbott India Limited is an India-based company that is engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolics, multi-specialty, vaccines and consumer health, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremalax (constipation), Pankreoflat (indigestion) and Duvadilan (preterm labor), among others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna, among others.

Brands

Abbott India

Pharmaceutical company

Brands

Abbott India

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+3.79+4.21+4.39+5.00+0.45+0.59+0.69+0.80
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Cash Dividend 
Ex. DateAug 2, 2022

Final • Div/Share: ₹ 145

Cash Dividend 
Ex. DateAug 2, 2022

Special • Div/Share: ₹ 130

Cash Dividend 
Ex. DateJul 19, 2021

Final • Div/Share: ₹ 120

See all events